Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Discovery and Structure-Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1).
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.
Therapy with Eculizumab for Patients with CD59 p.Cys89Tyr Mutation.
Posterior lobules of the cerebellum and information processing speed at various stages of multiple sclerosis.
The redesign of consumer cost sharing for specialty drugs at the California Health Insurance Exchange.
Acute visual loss after ipilimumab treatment for metastatic melanoma.
MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance.
Age-related myelin degradation burdens the clearance function of microglia during aging.
High Intensity Training May Reverse the Fiber Type Specific Decline in Myogenic Stem Cells in Multiple Sclerosis Patients.
Cerebral Microbleeds in Multiple Sclerosis Evaluated on Susceptibility-weighted Images and Quantitative Susceptibility Maps: A Case-Control Study.
Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation.
Olig2-Targeted G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Survival in Response to Lysolecithin-Induced Demyelination.
Weston-Hurst syndrome: a rare fulminant form of acute disseminated encephalomyelitis (ADEM).
Exercise Effects on Early Vocal Ultrasonic Communication Dysfunction in a PINK1 Knockout Model of Parkinson's Disease.
The impact of drugs for multiple sclerosis on sleep.
[Monoclonal antibodies, overview and outlook of a promising therapeutic option].
Longitudinal Study of Retinal Nerve Fiber Layer Thickness and Macular Volume in Patients With Neuromyelitis Optica Spectrum Disorder.
The Gas6/TAM System and Multiple Sclerosis.
Atf6α deficiency suppresses microglial activation and ameliorates pathology of experimental autoimmune encephalomyelitis.
Commentary on painful tonic spasms and brainstem involvement in a patient with neuromyelitis optica spectrum disorder.
The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?
Pathologic and Protective Roles for Microglial Subsets and Bone Marrow- and Blood-Derived Myeloid Cells in Central Nervous System Inflammation.
Novel molecular insights into the critical role of sulfatide in myelin maintenance/function.
The patient's perspective: How to create awareness for improving access to care and treatment of MS patients?
[Electrophysiological subtypes and long term prognosis of Guillain-Barré syndrome].
Pages
« first
‹ previous
…
790
791
792
793
794
795
796
797
798
…
next ›
last »